HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd International Conference on Orphan Drugs and Rare Diseases

March 17-19, 2025

March 17 -19, 2025 | Rome, Italy

Orphan Drugs 2023

Speaker at Orphan Drugs and Rare Diseases 2023 - Roy G Beran
Keynote Presentation
Roy G Beran, University of New South Wales, Australia

This presentation will explore what happens to a Patient With Epilepsy (PWE) when (s) he attends the Emergency Department (ED) of the local teaching hospital which often includes the administration of an Antiseizure Medication (ASM) that is not the ASM that the patient was taking [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Sergey Suchkov
Keynote Presentation
Sergey Suchkov, Sechenov University, Russian Federation

A new and upgraded approach to the diseased states and wellness, and to re-shape tomorrow’s healthcare whilst doing it today, resulted in a new global trend in the healthcare services, namely, Personalized and Precision Medicine (PPM). PPM as a Unique Entity demonstrating a [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 -  Daniel Scherman
Keynote Presentation
Daniel Scherman, Foundation for Rare Diseases, France

The French rare disease research and clinical field has been a pioneer by structuring itself through different action plans. Competence centres and Reference centres are organized within  Rare Disease Health Networks (Filières de Santé Maladies Rares), which ha [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Vivek Gupta
Keynote Presentation
Vivek Gupta, St. John’s University, United States

Aims: Malignant pleural mesothelioma (MPM) is a rare cancer of lungs’ pleural cavity, with minimally effective therapies available. Thus, there exists a necessity for drug repurposing which is an attractive strategy for drug development in MPM. Repurposing of an old FD [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Harsha Rajasimha
Keynote Presentation
Harsha Rajasimha, Jeeva Informatics Solutions Inc, United States

Traditional clinical research paradigms relying solely on brick and mortar in-person engagement between researchers and patients have failed to provide the scale and efficiencies needed in orphan products development. Patients with rare disease are geographically sparsely distrib [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 -  Jiao Fuyong
Oral Presentation
Jiao Fuyong, Shaanxi Provincial People’s Hospital, China

Kawasaki disease, it is a systemic vasioinflammatory disease in children of Asian descent, coronary artery injury is its major complication, the disease has now become a major cause of acquired heart disease in children. The etiology of Kawasaki disease is not fully clear, and it [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Fereshteh Sedaghat
Oral Presentation
Fereshteh Sedaghat, Sedaghat Memory Clinic, Iran (Islamic Republic of)

The proteoglycan named heparan sulfate (HS) is found in the extracellular matrix and also on cell surface and may represent one of the most biologically important glycoconjugates, playing essential role in a variety of different events at molecular level. Heparanase is an endo-gl [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Magali Taiel
Oral Presentation
Magali Taiel, GenSight Biologics, France

Leber hereditary optic neuropathy (LHON) is a rare, maternally inherited mitochondrial genetic disease with a continued high unmet medical need. Three primary point mutations in the mtDNA are responsible for LHON in approximately 90% of subjects: G3460A, G11778A and T14484C, loca [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - J. Somasekar
Oral Presentation
J. Somasekar, Jain University, India

A drug recommendation system using collaborative filtering in machine learning is a system that suggests drugs to users based on the preferences and patterns of similar users. Collaborative filtering is a popular technique in recommendation systems, and it can be applied to drug [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Angel Cuesta
Oral Presentation
Angel Cuesta , Complutense University of Madrid, Spain

Lack of expression or the inefficient function of the VHL protein raises the rare inherited cancer von Hippel-Lindau (VHL). This multi-systemic rare disease affects mainly CNS and retina (hemangioblastomas, HBs), pancreas, and kidneys (cysts and clear cell renal cell carcinomas, [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Kondakova O. B
Oral Presentation
Kondakova O. B, National Medical Research Center for Children's Health Federal state autonomous institution of the Russian Federation Ministry of Health, Russian Federation

Neurotransmitter deficiencies are rare neurological disorders with clinical onset during childhood. Its classical signs are hypotonia, movement disorders, autonomous dysregulations, and impaired development. The clinical symptoms of inherited neurotransmitters disorders often ove [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Kranthi Kumar Singamaneni
Oral Presentation
Kranthi Kumar Singamaneni, Chaitanya Bharathi Institute of Technology, India

Cyber security is the practice of defending computers, servers, mobile devices, electronic systems, networks, and data from malicious attacks. It's also known as information technology security or electronic information security. Cybersecurity plays a vital role in the contex [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Priyanka Wadhwa
Oral Presentation
Priyanka Wadhwa, Ikris Pharma Network Pvt Ltd, India

Rare diseases are a significant healthcare challenge worldwide, with an estimated 350 million people globally affected by one of over 7000 rare diseases. India, with the population of over 1.48 billion, is no exception. It is estimated that we have more than 70 million people aff [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Arti Sharma
Oral Presentation
Arti Sharma, Govt. P.G. College Prithvipur, India

Botulism is a neuroparalytic disease caused by botulinum neurotoxins (BoNTs) and has been reported as a potential bio warfare agent due to its extreme toxicity (~100 billion times more toxic than cyanide). BoNTs is produced by Gram positive; an obligate anaerobic and endospore fo [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Zeynep Unluturk
Oral Presentation
Zeynep Unluturk, University of Health Sciences Kocaeli Derince Training Hospital, Turkey

Neiman Pick disease type-C (NPC) is a rare lysosomal lipid storage disorder. NPC has a wide variety of clinical manifestations from rapidly fatal neonatal form to adult onset chronic neurodegenerative form. It is traditionally known as a childhood onset autosomal recessive, [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Vicki Ratner
Oral Presentation
Vicki Ratner, ESSIC - International Society for the Study of BPS, United States

Interstitial cystitis/bladder pain syndrome (IC/PBS) was once thought to be a rare disease as well as a psychosomatic disorder in women.  As a result, the disease went undiagnosed for hundreds of years.  IC/BPS is a condition of the bladder that can cause severe pain, u [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Paul L Kaufman
Oral Presentation
Paul L Kaufman, University of Wisconsin-Madison, United States

Glaucoma is a degenerative optic neuropathy that is the leading cause of preventable blindness worldwide. Roughly 3% of the adult human population has or will have glaucoma, and the prevalence increases with age. All races, both genders, and all 6 inhabitable continents comprise [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Wang Huaixiu
Poster Presentation
Wang Huaixiu, Shanxi Provincial Hospital, China

Objective: To investigate the effect of Eupalinolide B (EB) on amyotrophic lateral sclerosis (ALS). Case description: The 66-year-old femele patient experienced progressive right upper limb weakness and slowed speech speed in November, 2021. One month later, weakness of lower li [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Drake Carter
Poster Presentation
Drake Carter, Rosalind Franklin University of Medicine & Science, United States

Ophthalmological conditions are underreported in patients with KBG syndrome, which is classically described as the presentation of dental, developmental, intellectual, skeletal, and craniofacial abnormalities. KBG syndrome is diagnosed by the identification of variants in the ANK [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2023 - Daniel Wainstock
Poster Presentation
Daniel Wainstock, Georgetown University-PUC-Rio, Brazil

People living with a rare disease are amongst the most vulnerable groups in society. They have been historically marginalized and systematically stigmatized, especially in middle and low-income countries. It is estimated that 300 million people worldwide live with a rare disease. [....] » Read More

Will be updated soon......
Watsapp